CXT(CXT)
CXT
Q4 2026 EPS Estimate
$1.19
Nov 4, 2026 · Reports after close
Revenue Estimate
$497M
FY2026E EPS$4.30
FY2027E EPS$4.70
Analyst Sentiment
Wall St. Consensus
Buy7 analysts·Limited coverage
71
Score
6 Buy (86%)1 Hold (14%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
686%
Hold
114%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$65.00
+33.9%
Consensus
$65.00
+33.9%
Bull
$68.00
+40.0%
12-Month Target Range7 analysts
$65.00$65.00$68.00
Current $48.56Consensus
Current Price
$48.56
Upside to Consensus
$16.44
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.89%
EPS+9.25%
FY2028
Rev+3.30%
EPS+7.68%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.92B | $2.04B | $2.10B |
| Low | $1.91B | $2.01B | $2.09B |
| High | $1.93B | $2.06B | $2.11B |
| EBITDA Avg | $490M | $519M | $536M |
| Low | $487M | $512M | $533M |
| High | $492M | $524M | $539M |
| EBIT Avg | $376M | $398M | $411M |
| Low | $373M | $392M | $408M |
| High | $377M | $402M | $413M |
| Net Income Avg | $249M | $272M | $293M |
| Low | $246M | $253M | $291M |
| High | $252M | $284M | $295M |
| EPS Avg | $4.30 | $4.70 | $5.06 |
| Low | $4.24 | $4.36 | $5.01 |
| High | $4.34 | $4.90 | $5.09 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $497M | $545M | $449M | $510M | $511M | $568M | $477M | $521M |
| Low | $491M | $539M | $444M | $504M | $506M | $562M | $471M | $516M |
| High | $505M | $549M | $454M | $516M | $517M | $574M | $482M | $528M |
| EBITDA Avg | $127M | $139M | $115M | $130M | $130M | $145M | $122M | $133M |
| Low | $125M | $138M | $113M | $129M | $129M | $143M | $120M | $132M |
| High | $129M | $140M | $116M | $132M | $132M | $147M | $123M | $135M |
| EBIT Avg | $97M | $106M | $88M | $100M | $100M | $111M | $93M | $102M |
| Low | $96M | $105M | $87M | $99M | $99M | $110M | $92M | $101M |
| High | $99M | $107M | $89M | $101M | $101M | $112M | $94M | $103M |
| Net Income Avg | $70M | $81M | $41M | $69M | $73M | $87M | — | — |
| Low | $67M | $80M | $40M | $68M | $72M | $85M | — | — |
| High | $74M | $82M | $42M | $70M | $74M | $88M | — | — |
| EPS Avg | $1.21 | $1.39 | $0.71 | $1.18 | $1.26 | $1.49 | — | — |
| Low | $1.15 | $1.38 | $0.70 | $1.17 | $1.25 | $1.47 | — | — |
| High | $1.28 | $1.41 | $0.72 | $1.20 | $1.28 | $1.52 | — | — |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 4 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 2 | 1 / 2 |